CMA finalises pet care market reforms with direct implications for PE-backed consumer businesses as the UK regulator sharpens sector-specific intervention
The CMA (Competition and Markets Authority) has finalised its reforms to the UK pet care market, completing a market investigation that has significant structural implications for private equity-backed businesses operating in consumer-facing sectors. The reforms — reported in the context of their PE implications by PE Hub — follow a CMA market study that examined pricing, transparency, and competitive dynamics across veterinary services and pet food. The CMA's market investigation powers, exercised under the Enterprise Act 2002, allow the regulator to impose remedies directly on market structures — including divestiture requirements, behavioural undertakings, and price transparency obligations — without needing to prove a breach of competition law. In the pet care context, the finalised reforms are understood to focus on improving price transparency for consumers and addressing consolidation in veterinary chains, a sector that has seen intensive PE investment over the past decade. For PE sponsors holding platforms in veterinary services, pet insurance, or pet food manufacturing, the finalised remedies create immediate compliance obligations and may affect exit valuations where remedies constrain pricing flexibility or require operational changes. The CMA has been running parallel market investigations across several consumer sectors — including road fuel and infant formula — signalling a sustained regulatory posture of structural intervention in markets where consolidation has followed PE buy-and-build strategies.
Why this matters
CMA market investigation remedies sit at the intersection of competition law and corporate transactions, activating both regulatory and M&A practices. PE houses with pet care platform investments will need competition counsel to assess remedy compliance obligations and their effect on EBITDA (earnings before interest, tax, depreciation, and amortisation — the standard measure of operating profitability used in PE valuations) and hence exit multiples. The 'why now' trigger is the CMA's post-DMCC Act 2024 (Digital Markets, Competition and Consumers Act) posture of more assertive market-level intervention, particularly where consumer harm from consolidation is demonstrable. Firms advising on PE exits in healthcare-adjacent consumer sectors should expect CMA market investigation history to become a standard due diligence question for acquirers.
On the Ground
A trainee on a competition matter would assist with compliance gap analysis memos, mapping the CMA's finalised remedy package against the client's current business practices, and preparing regulatory notification drafting where any proposed transaction requires CMA merger control clearance in a now-remedied market.
Interview prep
Soundbite
CMA market investigation remedies now land directly on PE portfolio valuations — exit multiples in vet chains have to be repriced around compliance costs.
Question you might get
“What is the difference between a CMA merger control review and a market investigation, and why does the latter create more significant ongoing compliance risk for a PE portfolio company?”
Full answer
The CMA has finalised its pet care market reforms, completing a market investigation that imposes structural and behavioural remedies on a sector dominated by PE-backed veterinary consolidators. This matters for law firms because PE sponsors holding platforms in veterinary services face immediate compliance obligations that may reduce the pricing flexibility — and therefore the exit value — of their businesses. It connects to the broader CMA trend of using market investigation powers under the Enterprise Act 2002 to address consolidation in consumer sectors that attract PE buy-and-build strategies, rather than waiting for individual merger notifications to surface concerns. This approach — sector-wide remedy-setting rather than deal-by-deal review — represents a structural shift in how the CMA manages competitive dynamics, and advisers need to build it into every consumer sector due diligence.
My notes
saved